These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 3287299)
1. [Contribution of monoclonal antibodies within the framework of urothelial tumors of the bladder]. Chopin DK Pathol Biol (Paris); 1988 Apr; 36(4):301-8. PubMed ID: 3287299 [TBL] [Abstract][Full Text] [Related]
2. [Immunolabelling of urothelial bladder tumors. Value of 2 monoclonal antibodies and perspective in cytology]. Pluot M; Bahroum K; Joundi A; Ducrot P; Diebold MD Arch Anat Cytol Pathol; 1988; 36(3):69-74. PubMed ID: 2462408 [No Abstract] [Full Text] [Related]
3. Human transitional cell carcinoma in the NMRI-nu/nu mouse bladder: a new animal model for the in vivo use of monoclonal antibodies and cytotoxic agents. Huland E; Arndt R; Huland H Cancer Res; 1986 May; 46(5):2488-9. PubMed ID: 3697989 [TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies to cell surface antigens shared by chemically induced mouse bladder carcinomas. Hellström I; Hellström KE; Rollins N; Lee VK; Hudkins KL; Nepom GT Cancer Res; 1985 May; 45(5):2210-8. PubMed ID: 3986770 [TBL] [Abstract][Full Text] [Related]
6. Human bladder cancer cell-surface antigens recognized by murine monoclonal antibodies raised against T24 bladder cancer cells. Masuko T; Abe J; Yagita H; Hashimoto Y Jpn J Cancer Res; 1985 May; 76(5):386-94. PubMed ID: 3924712 [TBL] [Abstract][Full Text] [Related]
7. Production and characterization of mouse monoclonal antibodies to human bladder tumor-associated antigens. Young DA; Prout GR; Lin CW Cancer Res; 1985 Sep; 45(9):4439-46. PubMed ID: 3896480 [TBL] [Abstract][Full Text] [Related]
8. Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma. Genega EM; Hutchinson B; Reuter VE; Gaudin PB Mod Pathol; 2000 Nov; 13(11):1186-91. PubMed ID: 11106075 [TBL] [Abstract][Full Text] [Related]
9. Lewis X antigen immunostaining in the diagnosis of transitional cell carcinoma. Loy TS; Alexander CJ; Calaluce RD Mod Pathol; 1995 Aug; 8(6):587-90. PubMed ID: 8532688 [TBL] [Abstract][Full Text] [Related]
10. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II). Mizutani Y; Yoshida O; Bonavida B J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929 [TBL] [Abstract][Full Text] [Related]
11. Editorial comment on: immunoreactivity of p63 in monolayered and in vitro stratified human urothelial cell cultures compared with native urothelial tissue. Papatsoris A; Deliveliotis C Eur Urol; 2008 May; 53(5):1073. PubMed ID: 17980953 [No Abstract] [Full Text] [Related]
12. Urinary levels of soluble e-cadherin in the detection of transitional cell carcinoma of the urinary bladder. Shariat SF; Matsumoto K; Casella R; Jian W; Lerner SP Eur Urol; 2005 Jul; 48(1):69-76. PubMed ID: 15967254 [TBL] [Abstract][Full Text] [Related]
13. The essential role of interferon-gamma during interleukin-12 therapy for murine transitional cell carcinoma of the bladder. O'Donnell MA; Luo Y; Hunter SE; Chen X; Hayes LL; Clinton SK J Urol; 2004 Mar; 171(3):1336-42. PubMed ID: 14767344 [TBL] [Abstract][Full Text] [Related]
14. [The proliferating nuclear fraction as a prognostic factor in superficial bladder carcinomas]. Belloso L; Zugasti A; Urkia M; Arozena F; Blasco-Olaetxea E Arch Esp Urol; 1997 Oct; 50(8):831-6. PubMed ID: 9463280 [TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies against cell surface antigens present on human urinary bladder cancer cells. Masuko T; Yagita H; Hashimoto Y J Natl Cancer Inst; 1984 Mar; 72(3):523-30. PubMed ID: 6583438 [TBL] [Abstract][Full Text] [Related]
16. Bladder tumor infiltrating mature dendritic cells and macrophages as predictors of response to bacillus Calmette-Guérin immunotherapy. Ayari C; LaRue H; Hovington H; Decobert M; Harel F; Bergeron A; Têtu B; Lacombe L; Fradet Y Eur Urol; 2009 Jun; 55(6):1386-95. PubMed ID: 19193487 [TBL] [Abstract][Full Text] [Related]
17. Human bladder cancer associated antigens: evaluation of antigenicity in TCC tissues of different grades and in normal urothelium. Ben-Aïssa H; Paulie S; Gustafsson B; Håkansson L; Lagerkvist M; Gustafson H; Ahlstrand C; Perlmann P Anticancer Res; 1988; 8(3):443-9. PubMed ID: 3389746 [TBL] [Abstract][Full Text] [Related]
18. Induction and analysis of tumor immunity using anti-idiotypic antibodies. Hellström KE; Lee V; Nelson K; Hellström I Monogr Allergy; 1987; 22():212-21. PubMed ID: 3501835 [No Abstract] [Full Text] [Related]
19. Interleukin-12 immunotherapy of murine transitional cell carcinoma of the bladder: dose dependent tumor eradication and generation of protective immunity. O'Donnell MA; Luo Y; Hunter SE; Chen X; Hayes LL; Clinton SK J Urol; 2004 Mar; 171(3):1330-5. PubMed ID: 14767343 [TBL] [Abstract][Full Text] [Related]
20. [Monoclonal antibodies against transitional cell carcinoma assay tumor associated antigens in different grades bladder cancer patients]. Zhang H; Zhao Z; Sun H Zhonghua Wai Ke Za Zhi; 1996 Sep; 34(9):560-2. PubMed ID: 9594163 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]